Haemonetics | HAE - Umlaufvermögen

Aktienkurs
59.92
Täglich Wechseln
0.43 0.72%
Monatlich
2.27%
Jährlich
-8.55%
Q1 Prognose
58.11




Umlaufvermögen Veränderung Datum
Avanos Medical USD 355.4M 4M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cerus USD 167.13M 1.41M 2025-09
Cooper Companies USD 2.13B 27.4M 2025-12
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Globus Medical USD 2.13B 201.25M 2025-12
Haemonetics USD 943.67M 43.99M 2025-12
Hologic USD 3.84B 175.3M 2025-12
ICU Medical USD 1.19B 16.74M 2025-12
Intuitive Surgical USD 12.4B 927.3M 2025-12
Masimo USD 926M 122.3M 2025-12
Medtronic USD 24B 773M 2025-09
Merit Medical Systems USD 1.04B 54.62M 2025-12
Neogen USD 574.58M 50.52M 2025-09
OraSure Technologies USD 283.01M 18.43M 2025-09
Plus Therapeutics USD 9.83M 1.75M 2023-12
Quidel USD 1.45B 80.6M 2025-12
ResMed USD 3.82B 193.06M 2025-12
STAAR Surgical USD 311.54M 9.66M 2025-12
Steris USD 2.29B 179.9M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 81.3M 948K 2024-09
Teleflex USD 1.94B 47.65M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
US Physical Therapy USD 139.99M 1.56M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12